Hepatitis E Virus Infection in a Patient with Alcohol Related Chronic Liver Disease: a Case Report of Acute-on-chronic Liver Failure

Overview

Journal Virol J

Publisher Biomed Central

Specialty Microbiology

Date 2021 Dec 10

PMID 34886883

Citations 7

Authors

Anabella Fantilli

Sarah Daniela Lopez Villa

Alina Zerega

Guadalupe Di Cola

Luis Lopez

Maribel Wassaf Martinez

Maria Belen Pisano

Viviana Elizabeth Re

Affiliations

Soon will be listed here.

Abstract

Background: The hepatitis E virus (HEV) infection has been described as a causing factor for acute-on-chronic-liver-failure (ACLF) in patients with underlying chronic liver disease (CLD), such as chronic hepatitis or cirrhosis, which could end in the failure of one or more organs and high short-term mortality. There are scarce data about the association of HEV in patients with chronic liver disorders in South America.

Case Presentation: A 56-year-old hypertensive male with a history of type 2 diabetes was diagnosed with alcohol-related-liver cirrhosis in February 2019. A year later, the patient was admitted to hospital due to fatigue, jaundice and acholia. No evidence of hepatitis A virus, hepatitis B virus, hepatitis C virus, Epstein-Barr virus, herpes zoster virus and cytomegalovirus infections were found. Nevertheless, in February and March, 2020 the patient was positive for HEV-IgM and HEV-IgG, and HEV genotype 3 RNA was detected in sera. Afterwards, he presented grade I hepatic encephalopathy and, therefore, was diagnosed with acute hepatitis E-on-chronic liver disease. The patient reported a recent travel to the Argentine coast, where he consumed seafood. Besides, he reveled to have consumed pork meat and had no history of blood transfusion.

Conclusion: This report describes a unique case of hepatitis E virus infection in a patient with alcohol-related cirrhosis. This is the first report of a patient with HEV-related ACLF in Argentina and it invokes the importance of HEV surveillance and treatment among patients with CLD, such as alcohol-related cirrhosis.

Citing Articles

Viral hepatitis E: Clinical manifestations, treatment, and prevention.

Luo Q, Chen J, Zhang Y, Xu W, Liu Y, Xie C Liver Res. 2025; 8(1):11-21.

PMID: 39959034 PMC: 11771268. DOI: 10.1016/j.livres.2024.01.001.

Case of Fatal Hepatitis Related to HEV-3 Infection in Central Italy.

Borghi M, Graziani A, Marini D, Madonna E, Villano U, Suffredini E Viruses. 2025; 16(12.

PMID: 39772179 PMC: 11680277. DOI: 10.3390/v16121869.

Fatal invasive Aspergillus infection in an elderly patient with hepatitis E: A case report and literature review.

Wu J, Yu J, Li H, Wang Y, Xu R Medicine (Baltimore). 2024; 103(43):e40103.

PMID: 39470540 PMC: 11521067. DOI: 10.1097/MD.0000000000040103.

Pathogenesis and clinical features of severe hepatitis E virus infection.

Orosz L, Sarvari K, Dernovics A, Rosztoczy A, Megyeri K World J Virol. 2024; 13(2):91580.

PMID: 38984076 PMC: 11229844. DOI: 10.5501/wjv.v13.i2.91580.

A Clinical Course of Repeated Supratherapeutic Ingestion of Acetaminophen.

Shah N, Campbell H, Patel V, Moormeier J Cureus. 2024; 16(5):e59883.

PMID: 38854233 PMC: 11157473. DOI: 10.7759/cureus.59883.

References

Di Cola G, Fantilli A, Pisano M, Re V . Foodborne transmission of hepatitis A and hepatitis E viruses: A literature review. Int J Food Microbiol. 2020; 338:108986. DOI: 10.1016/j.ijfoodmicro.2020.108986. View

Smith D, Simmonds P, Izopet J, Oliveira-Filho E, Ulrich R, Johne R . Proposed reference sequences for hepatitis E virus subtypes. J Gen Virol. 2016; 97(3):537-542. PMC: 5588893. DOI: 10.1099/jgv.0.000393. View

Sridhar S, Teng J, Chiu T, Lau S, Woo P . Hepatitis E Virus Genotypes and Evolution: Emergence of Camel Hepatitis E Variants. Int J Mol Sci. 2017; 18(4). PMC: 5412450. DOI: 10.3390/ijms18040869. View

Atiq M, Shire N, Barrett A, Rouster S, Sherman K, Shata M . Hepatitis E virus antibodies in patients with chronic liver disease. Emerg Infect Dis. 2009; 15(3):479-81. PMC: 2681113. DOI: 10.3201/eid1503.080740. View

Fantilli A, Trinks J, Marciano S, Zarate F, Balderramo D, Martinez Wassaf M . Unexpected high seroprevalence of hepatitis E virus in patients with alcohol-related cirrhosis. PLoS One. 2019; 14(10):e0224404. PMC: 6812777. DOI: 10.1371/journal.pone.0224404. View

Lin X, Lin Q, Li S, Xie K, Hou J, Chen R . Hepatitis E virus re-infection accelerates hepatocellular carcinoma development and relapse in a patient with liver cirrhosis: A case report and review of literature. World J Hepatol. 2021; 12(12):1358-1366. PMC: 7772737. DOI: 10.4254/wjh.v12.i12.1358. View

Fousekis F, Mitselos I, Christodoulou D . Extrahepatic manifestations of hepatitis E virus: An overview. Clin Mol Hepatol. 2019; 26(1):16-23. PMC: 6940480. DOI: 10.3350/cmh.2019.0082. View

Ke W, Li X, Yu L, Lai J, Li X, Gao Z . Etiological investigation of fatal liver failure during the course of chronic hepatitis B in southeast China. J Gastroenterol. 2006; 41(4):347-51. DOI: 10.1007/s00535-005-1781-y. View

Doceul V, Bagdassarian E, Demange A, Pavio N . Zoonotic Hepatitis E Virus: Classiﬁcation, Animal Reservoirs and Transmission Routes. Viruses. 2016; 8(10). PMC: 5086606. DOI: 10.3390/v8100270. View

10.

Valenzuela V, Pinto J, Padilla M, Piscoya A, De Los Rios R, Surco Y . [Severe decompensation of hepatitis e in a patient with autoimmune hepatitis: a case report]. Rev Gastroenterol Peru. 2012; 32(2):187-91. View

11.

Marion-Audibert A, Tesse S, Graillot E, Phelip G, Radenne S, Duperret S . Lethal acute HEV superinfection on hepatitis B cirrhosis. Gastroenterol Clin Biol. 2010; 34(4-5):334-6. DOI: 10.1016/j.gcb.2010.02.003. View

12.

Haagsma E, Niesters H, van den Berg A, Riezebos-Brilman A, Porte R, Vennema H . Prevalence of hepatitis E virus infection in liver transplant recipients. Liver Transpl. 2009; 15(10):1225-8. DOI: 10.1002/lt.21819. View

13.

van der Eijk A, Pas S, de Man R . Hepatitis E virus: A potential threat for patients with liver disease and liver transplantation. Best Pract Res Clin Gastroenterol. 2017; 31(2):143-150. DOI: 10.1016/j.bpg.2017.03.006. View

14.

Szabo G, Saha B . Alcohol's Effect on Host Defense. Alcohol Res. 2015; 37(2):159-70. PMC: 4590613. View

15.

Sipeki N, Antal-Szalmas P, Lakatos P, Papp M . Immune dysfunction in cirrhosis. World J Gastroenterol. 2014; 20(10):2564-77. PMC: 3949265. DOI: 10.3748/wjg.v20.i10.2564. View

16.

Frias M, Lopez-Lopez P, Rivero A, Rivero-Juarez A . Role of Hepatitis E Virus Infection in Acute-on-Chronic Liver Failure. Biomed Res Int. 2018; 2018:9098535. PMC: 6046156. DOI: 10.1155/2018/9098535. View

17.

Garg H, Kumar A, Garg V, Sharma P, Sharma B, Sarin S . Clinical profile and predictors of mortality in patients of acute-on-chronic liver failure. Dig Liver Dis. 2011; 44(2):166-71. DOI: 10.1016/j.dld.2011.08.029. View

18.

Narayanan S, Abutaleb A, Sherman K, Kottilil S . Clinical features and determinants of chronicity in hepatitis E virus infection. J Viral Hepat. 2019; 26(4):414-421. PMC: 6437685. DOI: 10.1111/jvh.13059. View

19.

Sarin S, Choudhury A, Sharma M, Maiwall R, Al Mahtab M, Rahman S . Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019; 13(4):353-390. PMC: 6728300. DOI: 10.1007/s12072-019-09946-3. View

20.

Akyuz F, Cavus B, Pinarbasi B, Bozaci M, Baran B, Akyuz U . Cryptogenic liver cirrhosis and hepatitis E virus (HEV): Are they related?. Ann Hepatol. 2019; 18(4):585-589. DOI: 10.1016/j.aohep.2019.01.007. View